Extracellular Vesicle-Related Thrombosis in Viral Infection

References

• La Scola B, Audic S, Robert C, et al. A giant virus in amoebae. Science. 2003;299(5615):2033. doi:10.1126/science.108186712663918
   PubMed Web of Science ®Google Scholar
• Iyer LM, Balaji S, Koonin EV, Aravind L. Evolutionary genomics of nucleo – cytoplasmic large DNA viruses. Virus Res. 2006;117(1):156–184.16494962
   PubMed Web of Science ®Google Scholar
• Koonin EV, Yutin N. Evolution of the large nucleocytoplasmic DNA viruses of eukaryotes and convergent origins of viral gigantism. Adv Virus Res. 2019;103:167–202.30635076
   PubMed Web of Science ®Google Scholar
• Ali H, Ali AA, Atta MS, Cepica A. Common, emerging, vector-bone and infrequent abortgenic virus infections of cattle. Transbound Emerg Dis. 2012;59(1):11–25.21733134
   PubMed Web of Science ®Google Scholar
• Poirier EZ, Vignuzzi M. Virus population dynamics during infection. Curr Opin Virol. 2017;23:82–87.28456056
   PubMed Web of Science ®Google Scholar
• Tan B, Gao SJ. RNA epitranscriptomics: regulation of infection of RNA and DNA viruses by N6- methyladenosine (M6A). Rev Med Virol. 2018;28(4):e1983.29698584
   PubMed Web of Science ®Google Scholar
• Mayo MA, Pringle CR. Virus taxonomy – 1997. J Gen Virol. 1998;79(Pt 4):649–657.9568957
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423.31967327
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207.31995857
   PubMed Web of Science ®Google Scholar
• Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res. 2008;123(1):8–23. doi:10.1016/j.thromres.2008.06.00618667228
   PubMed Web of Science ®Google Scholar
• Nomura S. Extracellular vesicles and blood diseases. Int J Hematol. 2017;105(4):392–405. doi:10.1007/s12185-017-2180-x28130731
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoovogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383. doi:10.1083/jcb.20121113823420871
   PubMed Web of Science ®Google Scholar
• Ciardiello C, Cavallini L, Spinelli C, et al. Focus on extracellular vesicles: new frontiers of cell-to-cell communication in cancer. Int J Mol Sci. 2016;17(2):175–191. doi:10.3390/ijms1702017526861306
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/ncb159617486113
   PubMed Web of Science ®Google Scholar
• Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–593.19498381
   PubMed Web of Science ®Google Scholar
• Hoen EN, Cremer T, Gallo RC, Margolis LB. Extracellular vesicles and viruses: are they close relatives? Proc Natl Acad Sci U S A. 2016;113(33):9155–9161.27432966
   PubMed Web of Science ®Google Scholar
• Huang ME, Leonard JN. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J Extracell Vesicles. 2016;5:31027.27189348
   PubMed Web of Science ®Google Scholar
• Iraci N, Leonardi T, Gessler F, Vega B, Pluchino S. Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles. Int J Mol Sci. 2016;17(2):171.26861302
   PubMed Web of Science ®Google Scholar
• Alberro A, Sáenz-Cuesta M, Muñoz-Culla M, et al. Inflammaging and frailty status do not result in an increased extracellular vesicle concentration in circulation. Int J Mol Sci. 2016;17(7):1168.
   Web of Science ®Google Scholar
• Conde-Vancells J, Rodriguez-Suarez E, Embade N, et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res. 2008;7(12):5157–5166.19367702
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907–1920.20601276
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345.21423189
   PubMed Web of Science ®Google Scholar
• Baietti MF, Zhang Z, Mortier E, et al. Syndecan-synternin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677–685.22660413
   PubMed Web of Science ®Google Scholar
• György B, Szabó TG, Pásztói M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667–2688.21560073
   PubMed Web of Science ®Google Scholar
• Muhsin-Sharafaldine MR, Saunderson SC, Dunn AC, Faed JM, McLellan AD. Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget. 2016;7(35):56279–56294.27462921
   PubMedGoogle Scholar
• Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126(Pt 24):5553–5565.24105262
   PubMed Web of Science ®Google Scholar
• Nomura S. Microparticle and atherothrombotic diseases. J Atheroscler Thromb. 2016;23(1):1–9. doi:10.5551/jat.3232626412494
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Miller VM, Heit JA, Owen WG. Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods. 2012;375(1–2):207–214.22075275
   PubMed Web of Science ®Google Scholar
• Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med. 2009;13(3):454–471.19379144
   PubMed Web of Science ®Google Scholar
• Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res. 2012;110(2):356–369.22267840
   PubMed Web of Science ®Google Scholar
• Tricarico C, Clancy J, D’Souza-Schorey C. Biology and biogenesis of shed microvesicles. Small GTPases. 2017;8(4):220–232.27494381
   PubMedGoogle Scholar
• Battistelli M, Falcieri E. Apoptotic bodies: particular extracellular vesicles involved in intercellular communication. Biology (Basel). 2020;9(1):21.
   Web of Science ®Google Scholar
• Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 2010;39:407–427.20192774
   PubMed Web of Science ®Google Scholar
• Kaplan ZS, Jackson SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program. 2011;2011:51–61.22160012
   PubMed Web of Science ®Google Scholar
• Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1–11.23456661
   PubMed Web of Science ®Google Scholar
• Black LV, Saunderson SC, Coutinho FP, et al. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles. Immunol Cell Biol. 2015;94(5):430–438.26647968
   PubMed Web of Science ®Google Scholar
• Thery C, Boussac M, Véron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001;166(12):7309–7318.11390481
   PubMed Web of Science ®Google Scholar
• Bilyy RO, Shkandina T, Tomin A, et al. Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles. J Biol Chem. 2012;287(1):496–503.22074924
   PubMed Web of Science ®Google Scholar
• Hristov M, Erl W, Linder S, Weber PC. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood. 2004;104(9):2761–2766.15242875
   PubMed Web of Science ®Google Scholar
• Turiak L, Misjak P, Szabo TG, et al. Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/C mice. J Proteome. 2011;74(10):2025–2033.
   Web of Science ®Google Scholar
• Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97(3):425–434.17334510
   PubMed Web of Science ®Google Scholar
• Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis. 1999;10(4):201–210.10390120
   PubMed Web of Science ®Google Scholar
• Nomura S, Tandon NN, Nakamura T, Cone J, Kambayashi J. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis. 2001;158(2):277–287.11583705
   PubMed Web of Science ®Google Scholar
• Barry OP, Praticò D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest. 1998;102(1):136–144.9649567
   PubMed Web of Science ®Google Scholar
• Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 1999;99(3):348–353.9918520
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289.25288114
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.25979354
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10(5):619–624.18425114
   PubMed Web of Science ®Google Scholar
• Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011;71(11):3792–3801.21478294
   PubMed Web of Science ®Google Scholar
• Tomasoni S, Longaretti L, Rota C, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev. 2013;22(5):772–780.23082760
   PubMed Web of Science ®Google Scholar
• Borges FT, Reis LA, Schor N. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res. 2013;46(10):824–830.24141609
   PubMed Web of Science ®Google Scholar
• Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010;38(1):215–224.19850715
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics. 2009;9(21):4997–5000.19810033
   PubMed Web of Science ®Google Scholar
• Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol. 2003;19:397–422.14570575
   PubMed Web of Science ®Google Scholar
• Tian T, Wang Y, Wang H, Zhu Z, Xiao Z. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem. 2010;111(2):488–496.20533300
   PubMed Web of Science ®Google Scholar
• Janas T, Janas MM, Sapon K, Janas T. Mechanisms of RNA loading into exosomes. FEBS Lett. 2015;589(13):1391–1398.25937124
   PubMed Web of Science ®Google Scholar
• Kosaka N, Yoshioka Y, Hagiwara K, Tominaga N, Katsuda T, Ochiya T. Trash or treasure: extracellular microRNAs and cell-to-cell communication. Front Genet. 2013;4:173.24046777
   PubMedGoogle Scholar
• Schorey JS, Cheng Y, Singh PP, Smith VL. Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep. 2015;16(1):24–43.25488940
   PubMed Web of Science ®Google Scholar
• Alenquer M, Amorim MJ. Exosome biogenesis, regulation, and function in viral infection. Viruses. 2015;7(9):5066–5083.26393640
   PubMed Web of Science ®Google Scholar
• Miller HC, Stephan M. Hemorrhagic varicella: a case report and review of the complications of varicella in children. Am J Emerg Med. 1993;11(6):633–638.8240570
   PubMed Web of Science ®Google Scholar
• Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum. 2002;31(4):256–263.11836658
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med. 2004;10(12 Suppl):S110–S121.15577929
   PubMed Web of Science ®Google Scholar
• Squizzato A, Gerdes VE, Buller HR. Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost. 2005;93(3):403–410.15735787
   PubMed Web of Science ®Google Scholar
• Wang CC, Chang CT, Lin CL, Lin IC, Kao CH. Hepatitis C virus infection associated with an increased risk of deep vein thrombosis: a population-based cohort study. Medicine (Baltimore). 2015;94(38):e1585.26402820
   PubMed Web of Science ®Google Scholar
• Bunce PE, High SM, Nadjafi M, Stanley K, Liles WC, Christian MD. Pandemic H1N1 influenza infection and vascular thrombosis. Clin Infect Dis. 2011;52(2):e14–e17.21288835
   PubMed Web of Science ®Google Scholar
• Kiser KL, Badowski ME. Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection. Pharmacotherapy. 2010;30(12):1292–1302.21114396
   PubMed Web of Science ®Google Scholar
• Matta F, Yaekoub AY, Stein D. Human immunodeficiency virus infection and risk of venous thromboembolism. Am J Med Sci. 2008;336(5):402–406.19011397
   PubMed Web of Science ®Google Scholar
• Kishimoto C, Ochiai H, Sasayama S. Intracardiac thrombus in murine Coxsackievirus B3 myocarditis. Heart Vessels. 1992;7(2):76–81.1328146
   PubMedGoogle Scholar
• Friedman MG, Phillip M, Dagan R. Virus-specific IgA in serum, saliva, and tears of children with measles. Clin Exp Immunol. 1989;75(1):58–63.2495200
   PubMed Web of Science ®Google Scholar
• Hidaka Y, Sakai Y, Toh Y, Mori R. Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J Gen Virol. 1991;72(Pt 4):915–921.1849974
   PubMed Web of Science ®Google Scholar
• Key NS, Bach RR, Vercellotti GM, Moldow CF. Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest. 1993;68(6):645–651.8390591
   PubMed Web of Science ®Google Scholar
• Subeamaniam S, Scharrer I. Procoagulant activity during viral infections. Front Biosci. 2018;23:1060–1081.
   Web of Science ®Google Scholar
• Yu Y, Shen Y, Li J, et al. Viral infection related venous thromboembolism: potential mechanism and therapeutic targets. Ann Palliat Med. 2020;9(3):1257–1263.32312074
   PubMed Web of Science ®Google Scholar
• van Gorp EC, Suharti C, Ten Cate H, et al. Review: infectious diseases and coagulation disorders. J Infect Dis. 1999;180(1):176–186.10353876
   PubMed Web of Science ®Google Scholar
• Koupenova M, Vitseva O, Mackay CR, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood. 2014;124(5):791–802.24755410
   PubMed Web of Science ®Google Scholar
• Campbell RA, Schwertz H, Hottz ED, et al. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood. 2019;133(19):2013–2026.30723081
   PubMed Web of Science ®Google Scholar
• Koupenova M, Corkrey HA, Visteva O, et al. The role of platelet in mediating a response to human influenza infection. Nat Commun. 2019;10(1):1780.30992428
   PubMed Web of Science ®Google Scholar
• Rondina M, Tatsumi K, Bastarache JA, Mackman N. Microvesicle tissue factor activity and interleukin-8 levels are associated with mortality in patients with influenza A/H1N1 infection. Crit Care Med. 2016;44(7):e574–e578.26751613
   PubMed Web of Science ®Google Scholar
• van der Poll T, Levi M. Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol. 2012;10(5):632–638.22272914
   PubMed Web of Science ®Google Scholar
• Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000;355(9222):2210–2215.10881895
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Chen L, Schmaljohn AL. How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol. 2007;7(7):556–567.17589545
   PubMed Web of Science ®Google Scholar
• Wong G, Kobinger GP, Qiu X. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol. 2014;10(6):781–790.24742338
   PubMed Web of Science ®Google Scholar
• Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis. 2004;4(8):487–498.15288821
   PubMed Web of Science ®Google Scholar
• Antoniak S. The coagulation system in host defense. Res Pract Thromb Haemost. 2018;2(3):549–557.30046760
   PubMed Web of Science ®Google Scholar
• Short KR, Veldhuis Kroeze EJB, Reperant LA, Richard M, Kuiken T. Influenza virus and endothelial cells: a species specific relationship. Front Microbiol. 2014;5:653.25520707
   PubMed Web of Science ®Google Scholar
• Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015;101(21):1738–1747.26310262
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010;10(2):83–92.20113977
   PubMed Web of Science ®Google Scholar
• Ludwig A, Lucero-Obusan C, Schirmer P, Winston C, Holodniy M. Acute cardiac injury events </=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012. BMC Cardiovasc Disord. 2015;15:109.26423142
   PubMed Web of Science ®Google Scholar
• Marsden PA. Inflammation and coagulation in the cardiovascular system: the contribution of influenza. Circ Res. 2006;99(11):1152–1153.17122443
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258–264.18374680
   PubMed Web of Science ®Google Scholar
• Armstrong SM, Darwish I, Lee WL. Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection. Virulence. 2013;4(6):537–542.23863601
   PubMed Web of Science ®Google Scholar
• Feng Y, Hu L, Lu S, et al. Molecular pathology analyses of two fatal human infections of avian influenza A(H7N9) virus. J Clin Pathol. 2015;68(1):57–63.25378539
   PubMed Web of Science ®Google Scholar
• Muramoto Y, Ozaki H, Takada A, et al. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiol Immunol. 2006;50(1):73–81.16428877
   PubMed Web of Science ®Google Scholar
• Akiyama R, Komori I, Hiramoto R, Isonishi A, Matsumoto M, Fujimura Y. H1N1 influenza (Swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13. Intern Med. 2011;50(6):643–647.21422695
   PubMed Web of Science ®Google Scholar
• Tsujii N, Nogami K, Yoshizawa H, et al. Influenza-associated thrombotic microangiopathy with unbalanced von Willebrand factor and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 levels in a heterozygous protein S-deficient boy. Pediatr Int. 2016;58(9):926–929.27435311
   PubMed Web of Science ®Google Scholar
• Blum A, Hadas V, Burke M, Yust I, Kessler A. Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol. 2005;28(3):149–153.15813624
   PubMed Web of Science ®Google Scholar
• Baker JV, Duprez D. Biomarkers and HIV-associated cardiovascular disease. Curr Opin HIV AIDS. 2010;5(6):511–516.20978394
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr., Phair JP. Cardiovascular disease in HIV infection. Curr Opin HIV AIDS. 2011;6(4):266–271.21546831
   PubMed Web of Science ®Google Scholar
• Shen YM, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004;10(3):277–280.15247986
   PubMed Web of Science ®Google Scholar
• O’Brien MP, Zafar MU, Rodriguez JC, et al. Targeting thrombogenicity and inflammation in chronic HIV infection. Sci Adv. 2019;5(6):eaav5463. doi:10.1126/sciadv.aav546331206016
   PubMed Web of Science ®Google Scholar
• Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203. doi:10.1371/journal.pmed.005020318942885
   PubMed Web of Science ®Google Scholar
• Rodger AJ, Fox Z, Lundgren JD, et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis. 2009;200(6):973–983. doi:10.1086/60544719678756
   PubMed Web of Science ®Google Scholar
• Funderburg NT, Mayne E, Sieg SF, et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010;115(2):161–167. doi:10.1182/blood-2009-03-21017919828697
   PubMed Web of Science ®Google Scholar
• Funderburg NT, Zidar DA, Shive C, et al. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood. 2012;120(23):4599–4608. doi:10.1182/blood-2012-05-43394623065151
   PubMed Web of Science ®Google Scholar
• Hurley A, Smith M, Karpova T, et al. Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1. J Infect Dis. 2013;207(4):638–650. doi:10.1093/infdis/jis73023204166
   PubMed Web of Science ®Google Scholar
• Allie S, Stanley A, Bryer A, Meiring M, Combrinck MI. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients. Int J Stroke. 2015;10(8):1294–1296. doi:10.1111/ijs.1255026121272
   PubMed Web of Science ®Google Scholar
• Ellwanger JH, Veit TD, Chies JAB. Exosomes in HIV infection: a review and critical look. Infect Genet Evol. 2017;53:146–154. doi:10.1016/j.meegid.2017.05.02128546080
   PubMed Web of Science ®Google Scholar
• Welch JL, Stapleton JT, Okeoma CM. Vehicles of intercellular communication: exosomes and HIV-1. J Gen Virol. 2019;100(3):350–366. doi:10.1099/jgv.0.00119330702421
   PubMed Web of Science ®Google Scholar
• Gonzalez-Reimers E, Quintero-Platt G, Martin-Gonzalez C, Perez-Hernandez O, Romero-Acevedo L, Santolaria-Fernandez F. Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol. 2016;22(18):4427–4437. doi:10.3748/wjg.v22.i18.442727182154
   PubMed Web of Science ®Google Scholar
• Pircher J, Czermak T, Merkle M, et al. Hepatitis C virus induced endothelial inflammatory response depends on the functional expression of TNFalpha receptor subtype 2. PLoS One. 2014;9(11):e113351. doi:10.1371/journal.pone.011335125419735
   PubMed Web of Science ®Google Scholar
• Wald O, Pappo O, Safadi R, et al. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol. 2004;34(4):1164–1174. doi:10.1002/eji.20032444115048728
   PubMed Web of Science ®Google Scholar
• Falasca K, Mancino P, Ucciferri C, et al. Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias. Clin Invest Med. 2007;30(5):E167–E176. doi:10.25011/cim.v30i5.289217892758
   PubMed Web of Science ®Google Scholar
• Hodowanec AC, Lee RD, Brady KE, et al. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection. BMC Infect Dis. 2015;15:190. doi:10.1186/s12879-015-0920-125884329
   PubMed Web of Science ®Google Scholar
• Barone M, Viggiani MT, Amoruso A, et al. Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection. Gastroenterol Res Pract. 2015;2015:682174. doi:10.1155/2015/68217426000012
   PubMed Web of Science ®Google Scholar
• Lee CJ, Huang YC, Yang S, et al. Clinical features of coxsackievirus A4, B3 and B4 infections in children. PLoS One. 2014;9(2):e87391. doi:10.1371/journal.pone.008739124504149
   PubMed Web of Science ®Google Scholar
• Antoniak S, Mackman N. Coagulation, protease-activated receptors, and viral myocarditis. J Cardiovasc Transl Res. 2014;7(2):203–211. doi:10.1007/s12265-013-9515-724203054
   PubMed Web of Science ®Google Scholar
• Sutherland MR, Raynor CM, Leenknegt H, Wright JF, Pryzdial EL. Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A. 1997;94(25):13510–13514. doi:10.1073/pnas.94.25.135109391056
   PubMed Web of Science ®Google Scholar
• Sutherland MR, Friedman HM, Pryzdial EL. Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1. J Thromb Haemost. 2007;5(5):1055–1061. doi:10.1111/j.1538-7836.2007.02441.x17461934
   PubMed Web of Science ®Google Scholar
• Sutherland MR, Ruf W, Pryzdial EL. Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection. Blood. 2012;119(15):3638–3645. doi:10.1182/blood-2011-08-37681422374699
   PubMed Web of Science ®Google Scholar
• Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22(5):883–896. doi:10.1016/j.berh.2008.09.00719028369
   PubMed Web of Science ®Google Scholar
• Hyakutake M, Steinberg E, Disla E, Heller M. Concomitant infection with Epstein-Barr virus and cytomegalovirus infection leading to portal vein thrombosis. J Emerg Med. 2019;57(2):e49–e51. doi:10.1016/j.jemermed.2019.02.01031043339
   PubMed Web of Science ®Google Scholar
• Justo D, Finn T, Atzmony L, Guy N, Steinvil A. Thrombosis associated with acute cytomegalovirus infection: a meta-analysis. Eur J Intern Med. 2011;22(2):195–199. doi:10.1016/j.ejim.2010.11.00621402253
   PubMed Web of Science ®Google Scholar
• Simmonds P, Aiewsakun P. Virus classification – where do you draw the line? Arch Virol. 2018;163(8):2037–2046. doi:10.1007/s00705-018-3938-z30039318
   PubMed Web of Science ®Google Scholar
• Wong RSM, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003;326(7403):1358–1362. doi:10.1136/bmj.326.7403.135812816821
   PubMed Web of Science ®Google Scholar
• Chong PY, Chui P, Ling AE, et al. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med. 2004;128(2):195–204. doi:10.1043/1543-2165(2004)128<195:AODDTS>2.0.CO;214736283
   PubMed Web of Science ®Google Scholar
• Ng KHL, Wu AKL, Cheng VCC, et al. Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome. Postgrad Med J. 2005;81(956):e3. doi:10.1136/pgmj.2004.03004915937197
   PubMed Web of Science ®Google Scholar
• Yang M, Ng MHL, Li CK, et al. Thrombopoietin levels increased in patients with severe acute respiratory syndrome. Thromb Res. 2008;122(4):473–477. doi:10.1016/j.thromres.2007.12.02118314161
   PubMed Web of Science ®Google Scholar
• Shimizu M, Konishi A, Nomura S. Examination of biomarker expressions in sepsis-related DIC patients. Int J Gen Med. 2018;11:353–361. doi:10.2147/IJGM.S17368430254480
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761. doi:10.1016/S1473-3099(13)70204-423891402
   PubMed Web of Science ®Google Scholar
• Singh SK. Middle east respiratory syndrome virus pathogenesis. Semin Respir Crit Care Med. 2016;37(4):572–577. doi:10.1055/s-0036-158479627486737
   PubMed Web of Science ®Google Scholar
• Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020.
   Web of Science ®Google Scholar
• Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-Cov-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi:10.1016/j.jcv.2020.10436232305883
   PubMed Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. doi:10.1016/j.thromres.2020.04.02432353746
   PubMed Web of Science ®Google Scholar
• Lacour T, Semaan C, Genet T, Ivanes F. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients. Catheter Cardiovasc Interv. 2020.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhaven MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease; implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020;75:2950–2973.32311448
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.1476832073213
   PubMed Web of Science ®Google Scholar
• Griffin DO, Jensen A, Khan M, et al. Pulmonary embolism and increased levels of d-dimer in patients with coronavirus disease. Emerg Infect Dis. 2020;26(8).
   Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020.
   Web of Science ®Google Scholar
• Schwab A, Meyering SS, Lepence B, et al. Extracellular vesicles from infected cells: potential for direct pathogenesis. Front Microbiol. 2015;6:1132. doi:10.3389/fmicb.2015.0113226539170
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Fan J, Lyon C, Wan M, Hu Y. Role of extracellular vesicles in viral and bacterial infections: pathogenesis, diagnosis, and therapeutics. Theranostics. 2018;8(10):2709–2721. doi:10.7150/thno.2057629774070
   PubMed Web of Science ®Google Scholar
• Zhang W, Jiang X, Bao J, Wang Y, Liu H, Tang L. Exosomes in pathogen infections: a bridge to deliver molecules and link functions. Front Immunol. 2018;9:90. doi:10.3389/fimmu.2018.0009029483904
   PubMed Web of Science ®Google Scholar
• Brown M, Johnson LA, Leone DA, et al. Lymphatic exosomes promote dendritic cell migration along guidance cues. J Cell Biol. 2018;217(6):2205–2221. doi:10.1083/jcb.20161205129650776
   PubMed Web of Science ®Google Scholar
• Anderson MR, Kashanchi F, Jacobson S. Exosomes in viral disease. Neurotherapeutics. 2016;13(3):535–546. doi:10.1007/s13311-016-0450-627324390
   PubMed Web of Science ®Google Scholar
• Pleet ML, DeMarino C, Stonier SW, et al. Extracellular vesicles and Ebola virus: a new mechanism of immune evasion. Viruses. 2019;11(5):410. doi:10.3390/v11050410
   Web of Science ®Google Scholar
• Kesimer M, Scull M, Brighton B, et al. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 2009;23(6):1858–1868. doi:10.1096/fj.08-11913119190083
   PubMed Web of Science ®Google Scholar
• Suptawiwat O, Ruangrung K, Boonarkart C, et al. Microparticle and anti-influenza activity in human respiratory secretion. PLoS One. 2017;12(8):e0183717. doi:10.1371/journal.pone.018371728832645
   PubMed Web of Science ®Google Scholar
• Konadu KA, Huang MB, Roth W, et al. Isolation of exosomes from the plasma of HIV-1 positive individuals. J Vis Exp. 2016;107:e53495.
   Google Scholar
• Chettimada S, Lorenz DR, Misra V, et al. Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy. Sci Rep. 2018;8(1):7227. doi:10.1038/s41598-018-25515-429740045
   PubMed Web of Science ®Google Scholar
• Pérez PS, Romaniuk MA, Duette GA, et al. Extracellular vesicles and chronic inflammation during HIV infection. J Extracell Vesicles. 2019;8(1):1687275. doi:10.1080/20013078.2019.168727531998449
   PubMed Web of Science ®Google Scholar
• Plazolles N, Humbert JM, Vachot L, Verrier B, Hocke C, Halary F. Pivotal advance: the promotion of soluble DC-SIGN release by inflammatory signals and its enhancement of cytomegalovirus -mediated Cis- infection of myeloid dendritic cells. J Leukoc Biol. 2011;89(3):329–342. doi:10.1189/jlb.071038620940323
   PubMed Web of Science ®Google Scholar
• Walker JD, Maier CL, Pober JS. Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol. 2009;182(3):1548–1559. doi:10.4049/jimmunol.182.3.154819155503
   PubMed Web of Science ®Google Scholar
• Kuo HT, Ye X, Sampaio MS, Reddy P, Bunnapradist S. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Transplantation. 2010;90(10):1091–1098.20885340
   PubMed Web of Science ®Google Scholar
• Meckes DG, Raab-Traub N. Microvesicles and viral infection. J Virol. 2011;85(24):12844–12854.21976651
   PubMed Web of Science ®Google Scholar
• Wurdinger T, Gatson NN, Balaj L, Kaur B, Breakefield XO, Pegtel DM. Extracellular vesicles and their convergence with viral pathway. Adv Virol. 2012;2012:767694.22888349
   PubMedGoogle Scholar
• Delabranche X, Berger A, Boisramé-Helms J, Meziani F. Microparticles and infectious disease. Med Mal Infect. 2012;42(8):335–343.22766273
   PubMed Web of Science ®Google Scholar
• Coakley C, Maizels RM, Buck AH. Exosome and other extracellular vesicles: the new communicators in parasite infections. Trends Parasitol. 2015;31(10):477–489.26433251
   PubMed Web of Science ®Google Scholar
• Schorey JS, Harding CV. Extracellular vesicles and infectious diseases: new complexity to an old story. J Clin Invest. 2016;126(4):1181–1189.27035809
   PubMed Web of Science ®Google Scholar
• Raab-Traub N, Dittmer DP. Viral effects on the content and function of extracellular vesicles. Nat Rev Microbiol. 2017;15(9):559–572.28649136
   PubMed Web of Science ®Google Scholar
• Altan-Bonnet N, Perales C, Domingo E. Extracellular vesicles: vesicles of en bloc viral transmission. Virus Res. 2019;265:143–149.30928427
   PubMed Web of Science ®Google Scholar
• Urbanelli L, Buratta S, Tancini B, et al. The role of extracellular vesicles in viral infection and transmission. Vaccines (Basel). 2019;7(3):102.
   Web of Science ®Google Scholar
• Goncalves-Alves E, Saferding V, Schliehe C, et al. MicroRNA-155 controls T helper cell activation during viral infection. Front Immunol. 2019;10:1367.31275315
   PubMed Web of Science ®Google Scholar
• AmraneDjedidi R, Rousseau A, Larsen AK, et al. Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells. Thromb Res. 2020;187:170–179.32006891
   PubMed Web of Science ®Google Scholar
• Deffune E, Prudenciatti A, Moroz A. Mesenchymal stem cell (MSc) seretome: a possible therapeutic strategy for intensive-care COVID-19 patients. Med Hypotheses. 2020;142:109769.32371362
   PubMed Web of Science ®Google Scholar
• O’Driscoll L. Extracellular vesicles from mesenchymal stem cells as a COVID-19 treatment. Drug Discov Today. 2020.
   Web of Science ®Google Scholar
• Bari E, Ferrarotti I, Saracino L, Perteghella S, Torre ML, Corsico AG. Mesenchymal stromal cell secretome or severe COVID-19 infections: premises for the therapeutic use. Cells. 2020;9(4):924.
   PubMed Web of Science ®Google Scholar
• Kumar S, Zhi K, Mukherji A, Gerth K. Repurposing antiviral protease inhibitors using extracellular vesicles for potential therapy of COVID-19. Viruses. 2020;12(5):E486.32357553
   PubMed Web of Science ®Google Scholar
• Schmedes CM, Grover SP, Hisada YM, et al. Increased circulating extracellular vesicle tissue factor activity during orthohatavirus infection is associated with intravascular coagulation. J Infect Dis. 2019.
   Web of Science ®Google Scholar
• Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: immunology and treatment options. Clin Immunol. 2020;108448.32353634
   PubMed Web of Science ®Google Scholar
• Myer AD, Rishmawi AR, Kamucheka R, et al. Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation. J Thromb Haemost. 2020;18(2):399–410.31628728
   PubMed Web of Science ®Google Scholar
• Saenz-Pipaon G, San Martin P, Planell N, et al. Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD). J Extracell Vesicles. 2020;9:1729646.32158521
   PubMed Web of Science ®Google Scholar
• Zou B, She J, Wang Y, Ma X. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report. J Thromb Thrombolysis. 2020.
   Web of Science ®Google Scholar